Treatment for allergic eye disease
Part of Immune system & allergy, Lungs & breathing clinical trials.
This trial tests a new eye drop to reduce itching and other symptoms of allergic conjunctivitis, a condition where the eyes become red, itchy, and uncomfortable due to allergies. It may help people who have not found relief with current treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 10 and 65 years old.
- You have been diagnosed with allergic conjunctivitis in both eyes.
- You have had symptoms like itching, tearing, or discomfort for at least a short time.
- You have an itchy eye score of at least 50 on a 0-100 scale.
- You have some eye redness or staining when examined by a doctor.
- If you are a woman who can have children, you must use birth control and have a negative pregnancy test.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an eye drop called Daydrop Triple Action to see if it helps with eye itching and redness caused by allergies. It might be a good option if you have allergic conjunctivitis and have not used other allergy eye medications recently.
This trial tests an investigational eye drop called TL-925 to see if it can treat allergic conjunctivitis (eye allergies). If you have a history of eye allergies and a positive allergy skin test, you may be able to join.
This trial tests a new eye drop called DFL24498 to see if it helps people with dry eye disease. You may qualify if your dry eye is moderate to severe and other treatments haven't worked well for you.
This trial tests a new eye drop called diquafosol for people with a severe, active eye allergy called vernal keratoconjunctivitis. It aims to see if the drops can calm the allergy and help heal the surface of the eye.
This trial tests an investigational eye drop called TL-925 for people with seasonal allergic conjunctivitis (eye allergies triggered by pollen, grass, etc.). It aims to see if TL-925 can relieve symptoms like redness and itching.
This trial tests a new eye drop (0.4% solution) to see if it's safe and effective for people with dry eye. It's for both contact lens wearers and non-wearers who have dry eye symptoms, and aims to find a better way to relieve discomfort.
Hear when a new Atopic Keratoconjunctivitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.